Reta - 10MG
next-generation peptide Unlike traditional single-action compounds, Reta is known for its triple-agonist activity, targeting multiple pathways involved in appetite regulation, energy balance, and glucose control.
RETA-10 has been associated with:
Appetite suppression and reduced food intake
Enhanced fat loss and metabolic efficiency
Improved insulin sensitivity and glucose regulation
Potential support for overall body recomposition
This peptide is part of a new class of compounds designed to go beyond conventional approaches, offering a more comprehensive metabolic effect.
For research purposes only. Not approved for human use outside of clinical settings
















